ANOVA PANCAN result package

Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:10
iorio@ebi.ac.uk


Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer


Individual drug analysis: 287


Drug details and screening numbers

Drug Name: KIN001-244
Drug ID: 287
Synonyms:
Brand name:
Target: PDPK1 (PDK1)

Number of cell lines screened: 921
Screening concentration range(s): 0.078125 to 20 uM


Statistically significant associations identified = 4
association id
FEATURE
Drug id
Propr
Public
Drug Name
Drug Target
N FEATURE pos
N FEATURE neg
log max Conc tested
FEATURE neg logIC50 MEAN
FEATURE pos logIC50 MEAN
FEATURE deltaMEAN IC50
FEATURE IC50 effectSize
FEATURE neg Glass delta
FEATURE pos Glass delta
ANOVA FEATURE pval
Tissue ANOVA pval
MSI ANOVA pval
ANOVA FEATURE FDR %
a202
MLL2_mut
287
1
1
KIN001-244
PDPK1 (PDK1)
95
823
3
3.34
2.74
-0.601
0.48
0.49
0.44
8.84e-05
2.26e-42
6.13e-01
7.2
a300
EWSR1-FLI1_mut
287
1
1
KIN001-244
PDPK1 (PDK1)
17
901
3
3.3
2.38
-0.92
0.73 .
0.73 .
0.9 .
2.4e-04
2.83e-42
6.13e-01
13
a373
loss_cnaPANCAN360
287
1
1
KIN001-244
PDPK1 (PDK1)
25
893
3
3.26
4.02
0.76
0.6 .
0.6 .
0.62 .
3.83e-04
3.15e-42
6.14e-01
17
a509
loss_cnaPANCAN359_(CUL3)
287
1
1
KIN001-244
PDPK1 (PDK1)
18
900
3
3.26
4.2
0.942
0.75 .
0.75 .
0.94 .
7.52e-04
3.66e-42
6.14e-01
24


All-tests volcano plot